CIVLETY Trademark

Trademark Overview

On Friday, May 16, 2014, a trademark application was filed for CIVLETY with the United States Patent and Trademark Office. The USPTO has given the CIVLETY trademark a serial number of 86283065. The federal status of this trademark filing is REGISTERED as of Tuesday, June 19, 2018. This trademark is owned by Glaxo Group Limited. The CIVLETY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
civlety

General Information

Serial Number86283065
Word MarkCIVLETY
Filing DateFriday, May 16, 2014
Status700 - REGISTERED
Status DateTuesday, June 19, 2018
Registration Number5494816
Registration DateTuesday, June 19, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 29, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, June 19, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 19, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2018CASE RETURNED TO EXAMINATION
Monday, December 18, 2017NOTICE OF ALLOWANCE CANCELLED
Tuesday, November 14, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, June 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2017SOU EXTENSION 5 GRANTED
Tuesday, June 13, 2017SOU EXTENSION 5 FILED
Tuesday, June 27, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 13, 2017TEAS EXTENSION RECEIVED
Wednesday, January 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2017SOU EXTENSION 4 GRANTED
Thursday, December 1, 2016SOU EXTENSION 4 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Saturday, June 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 10, 2016SOU EXTENSION 3 GRANTED
Tuesday, May 31, 2016SOU EXTENSION 3 FILED
Tuesday, May 31, 2016TEAS EXTENSION RECEIVED
Tuesday, December 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2015SOU EXTENSION 2 GRANTED
Wednesday, November 18, 2015SOU EXTENSION 2 FILED
Friday, December 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 18, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 1, 2015SOU EXTENSION 1 GRANTED
Monday, June 1, 2015SOU EXTENSION 1 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Tuesday, December 16, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 15, 2014ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 12, 2014ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, September 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 2, 2014ASSIGNED TO EXAMINER
Thursday, May 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 20, 2014NEW APPLICATION ENTERED

Related Keywords

civlety pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological